Home/Filings/4/0001093557-22-000044
4//SEC Filing

Abbey Donald 4

Accession 0001093557-22-000044

CIK 0001093557other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 7:21 PM ET

Size

9.8 KB

Accession

0001093557-22-000044

Insider Transaction Report

Form 4
Period: 2022-03-08
Abbey Donald
EVP Quality
Transactions
  • Disposition to Issuer

    Common Stock

    2022-03-09$406.06/sh932$378,44551,409 total
  • Award

    Common Stock

    2022-03-08$0.00/sh+4,984$553,658 total
  • Disposition to Issuer

    Common Stock

    2022-03-09$406.06/sh1,317$534,77752,341 total
  • Disposition to Issuer

    Common Stock

    2022-03-09$406.06/sh1,180$479,14750,229 total
Footnotes (3)
  • [F1]Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
  • [F2]Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
  • [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Issuer

DEXCOM INC

CIK 0001093557

Entity typeother

Related Parties

1
  • filerCIK 0001534342

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 7:21 PM ET
Size
9.8 KB